Search

Search results

Current filters: Hepatitis C drugs, Hepatitis C, Treatment, Research summary

40 search results

FDA—Rare cases of liver injury with some hepatitis C treatments

2019, CATIE
Research summary - Webpage

About HCV drugs in Canada

From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage

Maviret for people with HCV and chronic kidney disease

From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage

Experience with Maviret in northern Italy

From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage

Germany—experience with Maviret after licensure

From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage

HCV cure and the long road to recovery

From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage

HCV treatment in advanced liver disease

From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir + voxilaprevir (Vosevi) for people with genotypes 1, 2 or 3 whose previous treatment failed

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir + voxilaprevir (Vosevi) for HCV re-treatment

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Glecaprevir + pibrentasvir (Maviret)—highly effective against genotype 3

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage